earnings Archives

Debra BorchardtFebruary 26, 2020

MedMen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) delivered its financial results for the second quarter of 2020 ending December 28, 2019. Revenue across MedMen’s operations in California, Nevada, New York, Illinois, and Florida increased to $44.1 million for the quarter, up 50% year-over-year and 11% sequentially. The company stated that the revenue figures did not […]

Debra BorchardtFebruary 26, 2020

New York-based Acreage Holdings, Inc. (ACRG-U.CN) (ACRGF) delivered fourth-quarter revenue of $21.1 million and full-year 2019 revenue of $74.1 million, a 101% and 251% increase, respectively, compared to the same periods in 2018. The net loss was a whopping $65 million versus last year’s $29 million for the same time period. The net loss for […]

Debra BorchardtFebruary 25, 2020

GW Pharmaceuticals plc (GWPH) announced financial results for the fourth quarter and full-year ended December 31, 2019, with total net product sales of Epidiolex of $104.5 million for the fourth quarter and $296.4 million for the full year. Total revenues were $109 million and the S&P Capital IQ estimate was for revenue of $80 million […]

Debra BorchardtFebruary 25, 2020

While other cannabis companies are restructuring, saddled with mountains of debt and lower than expected revenues, Valens GroWorks (TSXV: VLNS) (OTCQX: VLNCF) delivered a solid fourth quarter and fiscal year earnings report. Valens reported after the market closed on Monday that its revenue increased to $58.1 million for the fiscal year 2019. For the fourth quarter of […]

StaffFebruary 18, 2020

Cannabis testing and analytics firm Digipath, Inc. (OTCQB: DIGP) reported a 26% increase in revenue to $808,930 for the first quarter of 2020 ending December 31, 2019. This is compared to $642,115 in the first quarter of 2019, and gross profit of $403,449, which rose approximately 152% over the comparative quarter in 2019. The company was […]

Debra BorchardtFebruary 14, 2020

Cannabis venture capital firm Canopy Rivers Inc. (TSX: RIV)(OTC: CNPOF) reported its third-quarter financial results in Canadian Dollars for the three and nine months ending December 31, 2019. The operating income for the quarter was $1.8 million, a big drop from last year’s $8.3 million for the same time period. The company also delivered a […]

Debra BorchardtFebruary 13, 2020

Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT) announced its financial results for its fiscal third-quarter ending December 31, 2019. Total revenues for Neptune were $9.1 million, a sequential increase of $2.6 million or 41% over the second quarter ended September 30, 2019. This was also an increase of $2.6 million or 40% compared to $6,538 for the three-month period ended December […]

Debra BorchardtJanuary 15, 2020

Canadian-based cannabis company Organigram Holdings Inc. (NASDAQ:OGI) reported that its first-quarter 2020 revenue rose by 102% over last year to $25.15 million, which beat analyst estimates by $10.24 million. Last year the company reported $12.4 million for the first quarter of 2019. The earnings per share reported by Organigram were flat, but that also beat […]

Debra BorchardtJanuary 14, 2020

Aphria Inc. (TSX: APHA and NYSE: APHA) reported its results in Canadian dollars for the second quarter ending November 30, 2019, with revenue for adult-use cannabis increasing 46% sequentially to $29 million. Total net revenue decreased sequentially by 4% to $120.6 million but jumped 457% over last year’s second quarter. The drop from the first quarter for […]

Debra BorchardtJanuary 13, 2020

GW Pharmaceuticals plc (GWPH) reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. The cannabis-based biotech firm said that it expects total net product sales to be approximately $108 million for the fourth quarter and approximately $309 million for the year ending December 31, 2019. The […]

Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC

Functional Mushrooms Move Into Mainstream as Wellness Trend Grows

In other news

The Daily Hit: January 4, 2024

Connecticut Attorney General Tells Unlicensed Cannabis Events Company to Stop

Testing Concerns Lead to Quarantine for 70% of Mississippi MMJ Goods

Tag: earnings

MedMen Reports Revenue Of $44 Million, But A Net Loss Of $96 Million

Acreage Holdings Reports 2019 Revenue Of $74 Million, Net Loss Of $195 Million

GW Pharma Stock Slides Despite Strong Epidiolex Sales

Valens GroWorks Delivers Solid Quarter Amidst Challenging Backdrop

Digipath Reports 26% Increase In Revenue

Canopy Rivers Reports Drop In Income, Increasing Losses

Neptune Wellness Delivers Solid Quarter As Sales Increase

Organigram Adjusts To Canadian Slow Roll

Aphria Delivers Strong Quarter Despite Slight Decline In Revenue

GW Pharma Reports $108 Million For Fourth Quarter Sales

The Daily Hit - TEST TEST TEST

Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC

Functional Mushrooms Move Into Mainstream as Wellness Trend Grows

Get the latest cannabis news delivered right to your inbox

Get the latest cannabis news delivered right to your inbox